Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium

BACKGROUND: Alzheimer’s disease (AD) patients often express significant behavioral symptoms: for this reason, accessible related biomarkers could be very useful. Neuroinflammation is a key pathogenic process in both AD and delirium (DEL), a clinical condition with behavioral symptoms resembling thos...

Descripción completa

Detalles Bibliográficos
Autores principales: Conti, Elisa, Andreoni, Simona, Tomaselli, Davide, Storti, Benedetta, Brovelli, Francesco, Acampora, Roberto, Da Re, Fulvio, Appollonio, Ildebrando, Ferrarese, Carlo, Tremolizzo, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870594/
https://www.ncbi.nlm.nih.gov/pubmed/32705487
http://dx.doi.org/10.1007/s10072-020-04608-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870594/
https://www.ncbi.nlm.nih.gov/pubmed/32705487
http://dx.doi.org/10.1007/s10072-020-04608-x

Ejemplares similares